Drug Trial Radar · NCT00624767
A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients
Last checked: Nov 20, 2026Latest source record: May 20, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
Mar 2008
Primary completion
Apr 2008
Study completion May 2008
Sponsor
- Lead sponsor
- Nastech Pharmaceutical Company, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 27, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Insulin is a hormone which is produced by the human pancreas for the lowering of blood sugar. In patients who don't produce enough insulin, additional insulin must be given several times per day by injections. Nastech Pharmaceutical Company Inc. has developed a new insulin nasal spray, as a possible way to improve patient compliance with intensive insulin treatment plans. This study is being conducted to see how Nastech's insulin nasal spray affects post-meal glucose levels compared with rapid acting insulin (i.e., insulin aspart) in Type 2 diabetics who are already taking oral antidiabetic medications and/or insulin therapy. Insulin aspart is marketed as NovoLog® in the United States. The safety of insulin nasal spray and how well it is tolerated as compared to NovoLog will also be evaluated.
Conditions
- Diabetes Mellitus
Interventions
Insulin (recombinant human insulin)Drug
Insulin Nasal Spray at doses up to 200 IU.
NovoLogDrug
NovoLog at doses up to 30 IU
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate the effect on postprandial glycemic control of intranasal insulin compared to NovoLogTime frame: 4 hour Profile
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Diabetes and Glandular Disease Research Associates
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.